期刊
REVIEWS IN MEDICAL VIROLOGY
卷 28, 期 1, 页码 -出版社
WILEY
DOI: 10.1002/rmv.1958
关键词
cytomegalovirus; gB/MF59 vaccine; interruption of CMV transmission
类别
资金
- Medical Research Council (British) [G:0900466]
- Seventh Framework Programme - FP7 Marie Curie Action [316655]
- Medical Research Council [G0900466] Funding Source: researchfish
- MRC [G0900466] Funding Source: UKRI
In this review article, we consider results suggesting that transmission of human cytomegalovirus (HCMV) from a donor of a solid organ to an immunologically naive individual can be reduced. Two randomized controlled trials have been conducted recently, one of active immunization of recipients pretransplant and another of passive immunization with monoclonal antibodies specific for HCMV given at the time of transplant. Although the available data are encouraging-providing evidence of a reduction in the incidence of HCMV viraemia-they fall short of what would be required to prove definitively that transmission has been completely prevented. Here, we reflect on these studies and propose a set of 5 criteria, which, if satisfied in the future, could be taken as proof that active and/or passive immunization against HCMV effectively interrupts transmission of virus from the donor. We suggest that these criteria are considered when designing future randomized controlled trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据